dr. mok on overall survival data from the alex trial in alk lung cancer
Published 4 years ago • 524 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:52
dr. thiel on overall survival data from the carmena trial in mrcc
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
4:22
advanced-stage nsclc: overall survival data from flaura
-
0:49
dr. mok on plasma testing in lung cancer
-
1:28
dr. mok discusses developing lung cancer treatments
-
0:44
dr. mok on dacomitinib for first-line lung cancer treatment
-
6:02
alk-rearranged lung cancer
-
0:52
dr. stinchcombe on the benefit of alectinib in alk nsclc
-
8:02
updates informing the management of alk-rearranged mnsclc
-
2:20
dr. markman on overall survival as an endpoint in ovarian cancer trials
-
1:26
dr. solomon on the results of the phase 3 crown study in alk-positive nsclc
-
2:05
dr. gadgeel on the results of the bfast trial in alk lung cancer
-
2:26
dr. shaw on alectinib as first-line therapy in lung cancer
-
1:25
dr. kerrigan on remaining challenges in alk nsclc
-
2:39
a look at overall survival data in cancer clinical trials
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
6:37
ascend-4: upfront ceritinib in alk-rearranged nsclc
-
33:30
ilcn molecular challenges forum: alk pioneers and progress
-
2:39
esmo 2020 highlights on 1st line lorlatinib for alk nsclc: the crown study